Patient Data Articles & Analysis

Stroke has published “Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis”. This meta-analysis uses individual patient data from 7 different randomized controlled trials, including the CLOTBUST-ER trial, to show that “Sonothrombolysis was associated with a nearly 2-fold increase in the odds of complete ...

By Cerevast Medical, Inc.

The European Stroke Organization has chosen “Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis” for the September 2021 “Paper of the ...

By Cerevast Medical, Inc.

In the Headstart Programme, EIT Health decided to support 89 healthcare start-ups in Europe, including 17 teams from more progressing regions. Seven start-ups come from Italy, two from Portugal, Poland, and Estonia and one from Greece, Romania, Hungary, and Latvia. All the teams get €40 000 to develop their innovations and entice private investment. Start-ups will compete for an additional ...

By Longenesis

A complete redesign of the T-Stat was launched in 2020. New features included a sleek and strong exterior of powder coated metal, framed with a soft plastic bumper to prevent any damage in the hospital environment. Battery back-up was added to make patient ambulation and transfer seemless and without any interruption in patient data. WiFi access has been added to accommodate hospitals and labs ...

By Spectros Medical Devices Inc.

We are happy to have participated in the 10th edition of “Journées du GREPI”! Many interesting exchanges and a very good participation in the integrated workshop where the place of bronchial drainage in the improvement of the management of infectious exacerbations of bronchiectasis could be demonstrated. Program: On 24/11 from 16:00 to 17:30, Workshop “Infectious ...

By PhysioAssist

REDMOND, Wash – June 23, 2021 – EndoGastric Solutions® today released the GERDHelp™ mobile application that will virtually guide gastroesophageal reflux disease (GERD) sufferers through an individualized treatment pathway providing education and customized support along the patient journey. Patients can easily record GERD-related symptoms, as well as their frequency, ...

By EndoGastric Solutions, Inc.

Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. Data were presented at the Technology Heart Failure Therapeutics Conference, which focuses on device and ...

By Heart Failure Society of America, Inc. (HFSA)

Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to a strong signal toward reducing ...

By Heart Failure Society of America, Inc. (HFSA)

Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. Patients need to trust that their healthcare providers are utilizing their data to advance innovations that will help them in the future. Healthcare providers such as health systems and hospitals must trust external stakeholders to use that data for ...

By Segmed, Inc.

The Journal of Asthma published the results of a study that assessed asthma patients and their ability to perform high-quality daily spirometry with the AioCare system. The study has shown that home spirometry is safe without supervision and feasible for asthma patients. Abstract: Background: Self-management is an appealing strategy for the prevention of asthma exacerbations. This study aimed ...

By AioCare

Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it will be presenting data comparing DCISionRT? and its integrated Residual Risk subtype (RRt) with traditional clinicopathology features at the 39th Annual Miami Breast Cancer Conference (MBCC), being held on March 3 – 6, 2022 at the Fontainebleau Miami ...

By PreludeDx

Shanghai Ruijin Hospital recently announced that it has initiated an investigator-initiated clinical trial (IIT) to evaluate the safety and efficacy of Bofutrelvir administered by inhalation for post-exposure prophylaxis in close contacts of COVID-19 (NCT05415241). It is a single-arm, open-label, multi-dose exploratory clinical study with an enrolment of ~60 subjects who are close contacts of ...

By Frontier Biotechnologies Inc.

SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping each ...

By SeqOne S.A.S.

Throughout this week Longenesis will be intensively working with mentors and investors (including Skype and Bolt co-Founders) to create and validate a concept for post-COVID-19 data utilization for research, faster drug development and patient recruitment. We believe that the tools developed by Longenesis have found a perfect fit in solving challenges in data and patient cohort identification ...

By Longenesis

NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...

By SIGA Technologies, Inc.

Today, at the annual meeting of the American Society of Clinical Oncology (ASCO), Prognos Health and xCures announced a collaboration to enable real-world data access and insights for life science companies across multiple use cases. The multi-year agreement will enable linking and access to xCures de-identified data and Prognos healthcare data marketplace. “We are excited about combining ...

By xCures

MINNEAPOLIS, July 21, 2020 /PRNewswire/ — CVRx, Inc., a private medical device company, announced that the BeAT-HF phase III randomized clinical trial has completed enrollment in the post-market phase. CVRx has also enrolled the first patient in a heart failure (“HF”) registry which is designed to be a national repository of individual patient data from commercial BAROSTIM ...

By CVRx

Kahn-Sagol-Mac­cabi (KSM), the research and inno­va­tion cen­ter of Israel’s lead­ing HMO — Mac­cabi Health­care Ser­vices, and Valo Health, Inc. (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric ...

By Valo Health, Inc.

ARLINGTON, Mass., May 01, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported clinical data from a Phase 1b trial of KPI-012, its novel, cell-free secretome therapy for the treatment of severe ocular diseases driven ...

By Kala Pharmaceuticals, Inc.

Medical device and technology company Lazurite™ Holdings LLC announced today that it has been selected to participate in the MedTech Innovator 2022 Road Tour Mid-Stage pitch event in Boston, May 10-11. The event will take place at the Boston Convention and Exhibition Center, co-located with Device Talks Boston. Lazurite’s new ArthroFree™ Wireless Surgical Camera System recently ...

By Lazurite Holdings LLC.